CPB
39
2
AMZN
50
-5
ED
39
3
AME
65
-6
ADSK
58
-4
CVS
39
-11
EMN
62
-3
ABT
41
3
AA
67
-5
DG
74
-2
APH
45
-10
BF.B
59
-2
EL
56
4
BBY
45
-4
VIX
25
3
AMP
73
-3
CNX
52
-8
AAL
51
-2
DD
55
-4
CMCSA
42
8
CPB
39
2
AMZN
50
-5
ED
39
3
AME
65
-6
ADSK
58
-4
CVS
39
-11
EMN
62
-3
ABT
41
3
AA
67
-5
DG
74
-2
APH
45
-10
BF.B
59
-2
EL
56
4
BBY
45
-4
VIX
25
3
AMP
73
-3
CNX
52
-8
AAL
51
-2
DD
55
-4
CMCSA
42
8
Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. Nebius Group NV Industry Stock Comparison

Buy
56

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$25.23
Seasonality Move:
7.92%
Sell
33

NBIS
Nebius Group NV

Last Price:
$87.69
Seasonality Move:
-3.81%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.23. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy, Sell or Hold?

  • The current Nebius Group NV [NBIS] share price is $87.69. The Score for NBIS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NBIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $25.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBIS Stock Price Chart

What is Nebius Group NV's stock price today?

  • The Nebius Group NV share price today is $87.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.69 Buy
Relative Strength Index (14 RSI): 68.46 Buy
Chaikin Money Flow: 1409326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.36 - 23.18) Buy
Bollinger Bands (100): (20.82 - 26.96) Buy

NBIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.69 Sell
Relative Strength Index (14 RSI): 40.93 Sell
Chaikin Money Flow: -10263420 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.51 - 101.97) Sell
Bollinger Bands (100): (69.11 - 115.93) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.69 Buy
20-day SMA: 21.71 Buy
50-day SMA: 23.11 Buy
200-day SMA: 21.92 Buy
8-day EMA: 23.84 Buy
20-day EMA: 22.66 Buy
50-day EMA: 22.73 Buy
200-day EMA: 24.25 Buy

NBIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.51 Sell
20-day SMA: 93.1 Sell
50-day SMA: 107.39 Sell
200-day SMA: 63.92 Buy
8-day EMA: 94.3 Sell
20-day EMA: 96.51 Sell
50-day EMA: 98.74 Sell
200-day EMA: 73.21 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Nebius Group NV Earnings Growth & NBIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nebius Group NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):